{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:25:45Z","timestamp":1787869545608,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,6]]},"DOI":"10.7759\/cureus.93992","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T06:53:32Z","timestamp":1759820012000},"source":"Crossref","is-referenced-by-count":2,"title":["Exploring Ayurveda's Potential in Parkinson's Disease: A Comprehensive Narrative"],"prefix":"10.7759","author":[{"given":"Umesh","family":"Chikkanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivakumar","family":"Venkatram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharath","family":"Holla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan R","family":"Mahale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Bhargav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Nishitha","family":"Jasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore Kumar","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivarama","family":"Varambally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia LV","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015, 386:896-912. 10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey MG","year":"2010","unstructured":"Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010, 37:510-8. 10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden SK","year":"2003","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol. 2003, 157:1015-22. 10.1093\/aje\/kwg068","journal-title":"Am J Epidemiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau LM","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-35. 10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","unstructured":"Global, regional, and national burden of Parkinson's disease, 1990-2016. a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018, 17:939-53. 10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"ref6","article-title":"Estimation of the 2020 global population of Parkinson\u2019s disease (PD) [Abstract]","volume":"35","author":"Maserejian N","year":"2020","unstructured":"Maserejian N, Vinikoor-Imler L, Dilley A. Estimation of the 2020 global population of Parkinson\u2019s disease (PD) [Abstract]. Mov Disord. 2020, 35:198.","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000080090","article-title":"Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas","volume":"23","author":"Gourie-Devi M","year":"2004","unstructured":"Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK. Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas. Neuroepidemiology. 2004, 23:261-8. 10.1159\/000080090","journal-title":"Neuroepidemiology"},{"key":"ref8","article-title":"High occurrence and low recognition of Parkinsonism (and possible PD) in old age homes in Bangalore, South India","volume":"56","author":"Ragothaman M","year":"2008","unstructured":"Ragothaman M, Murgod UA, Gururaj G, Louis ED, Subbakrishna DK, Muthane UB. High occurrence and low recognition of Parkinsonism (and possible PD) in old age homes in Bangalore, South India. J Assoc Physicians India. 2008, 56:233-6.","journal-title":"J Assoc Physicians India"},{"key":"ref9","article-title":"A random sample survey for prevalence of major neurological disorders in Kolkata","volume":"124","author":"Das SK","year":"2006","unstructured":"Das SK, Biswas A, Roy T, Banerjee TK, Mukherjee CS, Raut DK, Chaudhuri A. A random sample survey for prevalence of major neurological disorders in Kolkata. Indian J Med Res. 2006, 124:163-72.","journal-title":"Indian J Med Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520360039008","article-title":"Prevalence of Parkinson's disease in the Parsi community of Bombay, India","volume":"45","author":"Bharucha NE","year":"1988","unstructured":"Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol. 1988, 45:1321-3. 10.1001\/archneur.1988.00520360039008","journal-title":"Arch Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.7.13.1715","article-title":"Levodopa, motor fluctuations and dyskinesia in Parkinson's disease","volume":"7","author":"M\u00fcller T","year":"2006","unstructured":"M\u00fcller T, Russ H. Levodopa, motor fluctuations and dyskinesia in Parkinson's disease. Expert Opin Pharmacother. 2006, 7:1715-30. 10.1517\/14656566.7.13.1715","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2015.03.009","article-title":"Complementary and alternative medicine in Indian Parkinson's disease patients","volume":"6","author":"Pandit AK","year":"2016","unstructured":"Pandit AK, Vibha D, Srivastava AK, Shukla G, Goyal V, Behari M. Complementary and alternative medicine in Indian Parkinson's disease patients. J Tradit Complement Med. 2016, 6:377-82. 10.1016\/j.jtcme.2015.03.009","journal-title":"J Tradit Complement Med"},{"key":"ref13","article-title":"Chikitsa sthana (Therapeutics section) Chapter 28 [in Sanskrit]","author":"Agnivesha","year":"2017","unstructured":"Agnivesha. Chikitsa sthana (Therapeutics section) Chapter 28 [in Sanskrit]. Charaka Samhita of Acharya Charaka, Dridhabala Krit. Acharya JT (ed): Chaukhamba Sanskrit Sansthan, Varanasi, India; 2017. Ver. 59."},{"key":"ref14","article-title":"Sutra sthana (Chapter of fundamentals) Chapter 20 [In Sanskrit]","author":"Agnivesha","year":"2017","unstructured":"Agnivesha. Sutra sthana (Chapter of fundamentals) Chapter 20 [In Sanskrit]. Charaka Samhita of Acharya Charaka, Dridhabala Krit. Acharya JT (ed): Chaukhamba Sanskrit Sansthan, Varanasi; 2017. Ver. 9."},{"key":"ref15","article-title":"Sidhi sthana (Successful treatment)  Chapter 9 [In Sanskrit]","author":"Agnivesha","year":"2017","unstructured":"Agnivesha. Sidhi sthana (Successful treatment)  Chapter 9 [In Sanskrit]. Charaka Samhita of Acharya Charaka, Dridhabala Krit. Acharya JT (ed): Chaukhamba Sanskrit Sansthan, Varanasi, India; 2017. Ver. 86."},{"key":"ref16","article-title":"Basavarajeeyam","author":"Basavaraja VS","year":"2019","unstructured":"Basavaraja VS. Basavarajeeyam. Krishna Murthy MS (ed): Chaukhamba Orientalia, Varanasi, India; 2019."},{"key":"ref17","unstructured":"AYUSH Research Portal. Evidence-based research data of Ayush systems at global level . (2020). Accessed: September 16, 2020: http:\/\/ayushportal.nic.in\/default.aspx."},{"key":"ref18","article-title":"Treatment of Parkinson's disease with the cowhage plant-Mucuna pruriens Bak","volume":"26","author":"Vaidya AB","year":"1978","unstructured":"Vaidya AB, Rajagopalan TG, Mankodi NA, Antarkar DS, Tathed PS, Purohit AV, Wadia NH. Treatment of Parkinson's disease with the cowhage plant-Mucuna pruriens Bak. Neurol India. 1978, 26:171-6.","journal-title":"Neurol India"},{"key":"ref19","article-title":"A study on Ayurvedic management of sakampa pakshaghata (paralysis agitans)","volume":"11","author":"Sivaramakrishna K","year":"1990","unstructured":"Sivaramakrishna K, Singh G, Hejamadi S. A study on Ayurvedic management of sakampa pakshaghata (paralysis agitans). Ayu. 1990, 11:13-7.","journal-title":"Ayu"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(00)00329-4","article-title":"Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease","volume":"176","author":"Nagashayana N","year":"2000","unstructured":"Nagashayana N, Sankarankutty P, Nampoothiri MR, Mohan PK, Mohanakumar KP. Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease. J Neurol Sci. 2000, 176:124-7. 10.1016\/s0022-510x(00)00329-4","journal-title":"J Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.1407","article-title":"Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters","volume":"18","author":"Manyam BV","year":"2004","unstructured":"Manyam BV, Dhanasekaran M, Hare TA. Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Phytother Res. 2004, 18:97-101. 10.1002\/ptr.1407","journal-title":"Phytother Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.028761","article-title":"Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study","volume":"75","author":"Katzenschlager R","year":"2004","unstructured":"Katzenschlager R, Evans A, Manson A, et al.. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004, 75:1672-7. 10.1136\/jnnp.2003.028761","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004175","article-title":"Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study","volume":"89","author":"Cilia R","year":"2017","unstructured":"Cilia R, Laguna J, Cassani E, et al.. Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study. Neurology. 2017, 89:432-8. 10.1212\/WNL.0000000000004175","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.01.014","article-title":"Daily intake of Mucuna pruriens in advanced Parkinson's disease: a 16-week, noninferiority, randomized, crossover, pilot study","volume":"49","author":"Cilia R","year":"2018","unstructured":"Cilia R, Laguna J, Cassani E, Cereda E, Raspini B, Barichella M, Pezzoli G. Daily intake of Mucuna pruriens in advanced Parkinson's disease: a 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord. 2018, 49:60-6. 10.1016\/j.parkreldis.2018.01.014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10248","article-title":"Systematic evaluation of rating scales for impairment and disability in Parkinson's disease","volume":"17","author":"Ramaker C","year":"2002","unstructured":"Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Mov Disord. 2002, 17:867-76. 10.1002\/mds.10248","journal-title":"Mov Disord"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz CG","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, et al.. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008, 23:2129-70. 10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score","volume":"26","author":"Jenkinson C","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing. 1997, 26:353-7. 10.1093\/ageing\/26.5.353","journal-title":"Age Ageing"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study","volume":"22","author":"Chaudhuri KR","year":"2007","unstructured":"Chaudhuri KR, Martinez-Martin P, Brown RG, et al.. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord. 2007, 22:1901-11. 10.1002\/mds.21596","journal-title":"Mov Disord"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050112","article-title":"Paralysis agitans and levodopa in \"Ayurveda\": ancient Indian medical treatise","volume":"5","author":"Manyam BV","year":"1990","unstructured":"Manyam BV. Paralysis agitans and levodopa in \"Ayurveda\": ancient Indian medical treatise. Mov Disord. 1990, 5:47-8. 10.1002\/mds.870050112","journal-title":"Mov Disord"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/014107689108400814","article-title":"Treatment of Parkinson's disease in 'Ayurveda' (ancient Indian system of medicine): discussion paper","volume":"84","author":"Gourie-Devi M","year":"1991","unstructured":"Gourie-Devi M, Ramu MG, Venkataram BS. Treatment of Parkinson's disease in 'Ayurveda' (ancient Indian system of medicine): discussion paper. J R Soc Med. 1991, 84:491-2. 10.1177\/014107689108400814","journal-title":"J R Soc Med"},{"key":"ref31","article-title":"Agrobotanical, nutritional and bioactive potential of unconventional legume - Mucuna","author":"Sridhar KR","year":"2007","unstructured":"Sridhar KR, Bhat R. Agrobotanical, nutritional and bioactive potential of unconventional legume - Mucuna. Livestock Res Rural Dev. 2007, 19:http:\/\/www.lrrd.org\/lrrd19\/9\/srid19126.htm."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2010.03.003","article-title":"Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25-35 in PC12 cells","volume":"28","author":"Ma W","year":"2010","unstructured":"Ma W, Yuan L, Yu H, Ding B, Xi Y, Feng J, Xiao R. Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25-35 in PC12 cells. Int J Dev Neurosci. 2010, 28:289-95. 10.1016\/j.ijdevneu.2010.03.003","journal-title":"Int J Dev Neurosci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.31.149","article-title":"Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid beta protein (25--35)-induced toxicity in cultured rat cortical neurons","volume":"31","author":"Ban JY","year":"2008","unstructured":"Ban JY, Nguyen HT, Lee HJ, et al.. Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid beta protein (25--35)-induced toxicity in cultured rat cortical neurons. Biol Pharm Bull. 2008, 31:149-53. 10.1248\/bpb.31.149","journal-title":"Biol Pharm Bull"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2006.00259.x","article-title":"Neuroprotective effects of stearic acid against toxicity of oxygen\/glucose deprivation or glutamate on rat cortical or hippocampal slices","volume":"27","author":"Wang ZJ","year":"2006","unstructured":"Wang ZJ, Li GM, Tang WL, Yin M. Neuroprotective effects of stearic acid against toxicity of oxygen\/glucose deprivation or glutamate on rat cortical or hippocampal slices. Acta Pharmacol Sin. 2006, 27:145-50. 10.1111\/j.1745-7254.2006.00259.x","journal-title":"Acta Pharmacol Sin"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.02.006","article-title":"Neuroprotective effects of the beta-carboline abecarnil studied in cultured cortical neurons and organotypic retinal cultures","volume":"52","author":"Ruscher K","year":"2007","unstructured":"Ruscher K, Rzeczinski S, Thein E, Freyer D, Victorov IV, Lam TT, Dirnagl U. Neuroprotective effects of the beta-carboline abecarnil studied in cultured cortical neurons and organotypic retinal cultures. Neuropharmacology. 2007, 52:1488-95. 10.1016\/j.neuropharm.2007.02.006","journal-title":"Neuropharmacology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-000-0659-y","article-title":"Protective effect of phytic acid hydrolysis products on iron-induced lipid peroxidation of liposomal membranes","volume":"35","author":"Miyamoto S","year":"2000","unstructured":"Miyamoto S, Kuwata G, Imai M, Nagao A, Terao J. Protective effect of phytic acid hydrolysis products on iron-induced lipid peroxidation of liposomal membranes. Lipids. 2000, 35:1411-3. 10.1007\/s11745-000-0659-y","journal-title":"Lipids"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-009-9236-1","article-title":"Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection","volume":"40","author":"Akaike A","year":"2010","unstructured":"Akaike A, Takada-Takatori Y, Kume T, Izumi Y. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci. 2010, 40:211-6. 10.1007\/s12031-009-9236-1","journal-title":"J Mol Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.28.947","article-title":"Isolation of isoflavones inhibiting DOPA decarboxylase from fungi and streptomyces","volume":"28","author":"Umezawa H","year":"1975","unstructured":"Umezawa H, Tobe H, Shibamoto N, Nakamura F, Nakamura K. Isolation of isoflavones inhibiting DOPA decarboxylase from fungi and streptomyces. J Antibiot (Tokyo). 1975, 28:947-52. 10.7164\/antibiotics.28.947","journal-title":"J Antibiot (Tokyo)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/BF00219970","article-title":"Ferric ion-induced lipid peroxidation in erythrocyte membranes: effects of phytic acid and butylated hydroxytoluene","volume":"95","author":"Ko KM","year":"1990","unstructured":"Ko KM, Godin DV. Ferric ion-induced lipid peroxidation in erythrocyte membranes: effects of phytic acid and butylated hydroxytoluene. Mol Cell Biochem. 1990, 95:125-31. 10.1007\/BF00219970","journal-title":"Mol Cell Biochem"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2011.0148","article-title":"Effects of traditional Japanese massage therapy on various symptoms in patients with Parkinson's disease: a case-series study","volume":"18","author":"Donoyama N","year":"2012","unstructured":"Donoyama N, Ohkoshi N. Effects of traditional Japanese massage therapy on various symptoms in patients with Parkinson's disease: a case-series study. J Altern Complement Med. 2012, 18:294-9. 10.1089\/acm.2011.0148","journal-title":"J Altern Complement Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3822\/ijtmb.v9i1.287","article-title":"Massage therapy treatment and outcomes for a patient with Parkinson's disease: a case report","volume":"9","author":"Casciaro Y","year":"2016","unstructured":"Casciaro Y. Massage therapy treatment and outcomes for a patient with Parkinson's disease: a case report. Int J Ther Massage Bodywork. 2016, 9:11-8. 10.3822\/ijtmb.v9i1.287","journal-title":"Int J Ther Massage Bodywork"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.70066\/jahm.v13i7.1760","article-title":"Integrated management of Parkinson\u2019s disease - a case report","volume":"13","author":"Koralli A","year":"2025","unstructured":"Koralli A, Sivakaran N, Gayathri BG, Dimple D. Integrated management of Parkinson\u2019s disease - a case report. J Ayurveda Holistic Med. 2025, 13:69-76. 10.70066\/jahm.v13i7.1760","journal-title":"J Ayurveda Holistic Med"},{"key":"ref43","article-title":"Sidhi sthana (Successful treatment) Chapter 1 [In Sanskrit]","author":"Agnivesha","year":"2017","unstructured":"Agnivesha. Sidhi sthana (Successful treatment) Chapter 1 [In Sanskrit]. Charaka Samhita of Acharya Charaka, Dridhabala Krit. Acharya JT (ed): Chaukhamba Sanskrit Sansthan, Varanasi, India; 2017. Ver. 27-30."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease","volume":"30","author":"Keshavarzian A","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, et al.. Colonic bacterial composition in Parkinson's disease. Mov Disord. 2015, 30:1351-60. 10.1002\/mds.26307","journal-title":"Mov Disord"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos D","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, et al.. Colonic inflammation in Parkinson's disease. Neurobiol Dis. 2013, 50:42-8. 10.1016\/j.nbd.2012.09.007","journal-title":"Neurobiol Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020376","article-title":"Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson's Disease","volume":"9","author":"Hegelmaier T","year":"2020","unstructured":"Hegelmaier T, Lebbing M, Duscha A, et al.. Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson's Disease. Cells. 2020, 9:10.3390\/cells9020376","journal-title":"Cells"},{"key":"ref47","article-title":"Astanga Hridaya (The heart of eight limbs) [Book in Sanskrit]","author":"Vagbhata","year":"2018","unstructured":"Vagbhata. Astanga Hridaya (The heart of eight limbs) [Book in Sanskrit]. Paradakara Bhisagacarya HS (ed): Chaukhamba Sanskrit Sansthan, Varanasi, India; 2018."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-009-0044-2","article-title":"Intranasal drug delivery: a novel approach","volume":"61","author":"Chugh Y","year":"2009","unstructured":"Chugh Y, Kapoor P, Kapoor AK. Intranasal drug delivery: a novel approach. Indian J Otolaryngol Head Neck Surg. 2009, 61:90-4. 10.1007\/s12070-009-0044-2","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2016.08.020","article-title":"Management of Parkinson's disease in Ayurveda: medicinal plants and adjuvant measures","volume":"197","author":"Pathak-Gandhi N","year":"2017","unstructured":"Pathak-Gandhi N, Vaidya AD. Management of Parkinson's disease in Ayurveda: medicinal plants and adjuvant measures. J Ethnopharmacol. 2017, 197:46-51. 10.1016\/j.jep.2016.08.020","journal-title":"J Ethnopharmacol"},{"key":"ref50","article-title":"Guideline on clinical investigation of medicinal products in the treatment of Parkinson\u02b9s Disease","year":"2012","unstructured":"Guideline on clinical investigation of medicinal products in the treatment of Parkinson\u02b9s Disease. European Medicines Agency, London, UK; 2012. https.\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-treat...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415653-exploring-ayurvedas-potential-in-parkinsons-disease-a-comprehensive-narrative","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T06:53:34Z","timestamp":1759820014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415653-exploring-ayurvedas-potential-in-parkinsons-disease-a-comprehensive-narrative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.93992","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}